CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluating the Immunogenicity and Safety of 9-valent Human Papillomavirus(Type6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine in Chinese Females Aged 9 to 45 Years: A Phase 3, Open-label, Non-randomised Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04895020
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:49.291019+00:00
Published At: 2024-04-17T00:00:00+00:00
Record Updated At: 2024-04-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HPV Infections", "Cervical Cancer", "Vulvar Cancer", "Vaginal Cancer", "CIN1", "CIN2", "CIN 3", "VaIN1", "VaIN2", "VaIN3", "Genital Wart", "VIN 1", "VIN 2", "VIN 3", "AIS"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-04-17"
protocolSection.identificationModule.nctId: "NCT04895020"
protocolSection.identificationModule.officialTitle: "Evaluating the Immunogenicity and Safety of 9-valent Human Papillomavirus(Type6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine in Chinese Females Aged 9 to 45 Years: A Phase 3, Open-label, Non-randomised Clinical Trial"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.